Display options
Cite
Guiu B, Colombat S, Piron L, et al. Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics. Cancers (Basel). 2019;11(7)doi: 10.3390/cancers11070987.
Guiu, B., Colombat, S., Piron, L., Hermida, M., Allimant, C., Pierredon-Foulongne, M. A., Belgour, A., Escal, L., Cassinotto, C., & Boulin, M. (2019). Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics. Cancers, 11(7), . https://doi.org/10.3390/cancers11070987
Guiu, Boris, et al. "Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics." Cancers vol. 11,7 (2019). doi: https://doi.org/10.3390/cancers11070987
Guiu B, Colombat S, Piron L, Hermida M, Allimant C, Pierredon-Foulongne MA, Belgour A, Escal L, Cassinotto C, Boulin M. Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics. Cancers (Basel). 2019 Jul 15;11(7). doi: 10.3390/cancers11070987. PMID: 31311170; PMCID: PMC6678754.
Copy Download .nbib Format: NLM
Share it on

Cancers (Basel). 2019 Jul 15;11(7). doi: 10.3390/cancers11070987.

Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics.

Cancers

Boris Guiu, Sébastient Colombat, Lauranne Piron, Margaux Hermida, Carole Allimant, Marie-Ange Pierredon-Foulongne, Ali Belgour, Laure Escal, Christophe Cassinotto, Mathieu Boulin

Affiliations

  1. Department of Radiology, St-Eloi University Hospital, 34980 Montpellier, France. [email protected].
  2. Department of Pharmacy, Dijon University Hospital, 21000 Dijon, France.
  3. Department of Radiology, St-Eloi University Hospital, 34980 Montpellier, France.

PMID: 31311170 PMCID: PMC6678754 DOI: 10.3390/cancers11070987

[No abstract available.]

Keywords: HCC; chemoembolization

References

  1. Leuk Res. 1999 Jun;23(6):539-48 - PubMed
  2. J Vasc Interv Radiol. 2005 Apr;16(4):507-13 - PubMed
  3. Cancer. 1975 Oct;36(4):1250-7 - PubMed
  4. Sel Cancer Ther. 1991 Summer;7(2):39-48 - PubMed
  5. J Vasc Interv Radiol. 2008 Oct;19(10):1490-6 - PubMed
  6. Cardiovasc Intervent Radiol. 2010 Feb;33(1):41-52 - PubMed
  7. Eur Radiol. 2011 Aug;21(8):1719-26 - PubMed
  8. Anticancer Drugs. 2011 Sep;22(8):741-8 - PubMed
  9. Korean J Hepatol. 2011 Mar;17(1):51-60 - PubMed
  10. Cardiovasc Intervent Radiol. 2012 Oct;35(5):980-5 - PubMed
  11. J Hepatol. 2012 Mar;56(3):609-17 - PubMed
  12. J Vasc Interv Radiol. 2012 Feb;23(2):257-64.e4 - PubMed
  13. Aliment Pharmacol Ther. 2014 Jun;39(11):1301-13 - PubMed
  14. Br J Cancer. 2014 Jul 15;111(2):255-64 - PubMed
  15. J Vasc Interv Radiol. 2015 Feb;26(2):262-70 - PubMed
  16. AJR Am J Roentgenol. 2014 Dec;203(6):W706-14 - PubMed
  17. J Hepatol. 2016 May;64(5):1090-1098 - PubMed
  18. Dig Liver Dis. 2016 Jun;48(6):571-7 - PubMed
  19. Cardiovasc Intervent Radiol. 2016 Oct;39(10):1379-91 - PubMed
  20. Eur Radiol. 2017 Apr;27(4):1431-1439 - PubMed
  21. Cardiovasc Intervent Radiol. 2018 Apr;41(4):587-593 - PubMed
  22. J Hepatol. 2018 Jul;69(1):182-236 - PubMed
  23. Future Oncol. 2018 Nov;14(26):2761-2772 - PubMed
  24. Cardiovasc Intervent Radiol. 2019 Sep;42(9):1322-1328 - PubMed
  25. Cancer Treat Rep. 1984 May;68(5):739-47 - PubMed

Publication Types

Grant support